BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37384755)

  • 41. The long noncoding RNA LINC00483 promotes lung adenocarcinoma progression by sponging miR-204-3p.
    Yang S; Liu T; Sun Y; Liang X
    Cell Mol Biol Lett; 2019; 24():70. PubMed ID: 31889958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway.
    Li M; Liu Z; Hou Z; Wang X; Shi H; Li Y; Xiao X; Tang Z; Yang J; Luo Y; Zhang M; Chen M
    Thorac Cancer; 2023 May; 14(14):1223-1238. PubMed ID: 36944484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S; Wang X; Zhang Z; Liu D
    Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Annexin A13 predicts poor prognosis for lung adenocarcinoma patients and accelerates the proliferation and migration of lung adenocarcinoma cells by modulating epithelial-mesenchymal transition.
    Xue GL; Zhang C; Zheng GL; Zhang LJ; Bi JW
    Fundam Clin Pharmacol; 2020 Dec; 34(6):687-696. PubMed ID: 32145097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

  • 46. JAM2 is a prognostic biomarker and inhibits proliferation, metastasis and epithelial-mesenchymal transition in lung adenocarcinoma.
    Dong Y; Zhang J; Xie S; Di S; Fan B; Gong T
    J Gene Med; 2024 Feb; 26(2):e3679. PubMed ID: 38404047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2.
    Wang J; Yao S; Diao Y; Geng Y; Bi Y; Liu G
    Thorac Cancer; 2020 Jun; 11(6):1396-1405. PubMed ID: 32220063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
    Feng H; Zhang Z; Qing X; French SW; Liu D
    Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mortal Obligate RNA Transcript Inhibits Cancer Cell Invasion and Migration in Lung Adenocarcinoma by Downregulating miRNA-223.
    Huang Y; Zhuang Q; Zhuang W
    Cancer Biother Radiopharm; 2020 Jun; 35(5):345-350. PubMed ID: 32160014
    [No Abstract]   [Full Text] [Related]  

  • 50. RTKN2 Inhibits the Growth, Migration, Invasion and Glycolysis of Lung Adenocarcinoma Cells by Inactivating the NF-κB Signalling Pathway.
    Wang N; Wang J
    Biochem Genet; 2023 Oct; 61(5):2135-2148. PubMed ID: 36952123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DUBR suppresses migration and invasion of human lung adenocarcinoma cells via ZBTB11-mediated inhibition of oxidative phosphorylation.
    Nie W; Hu MJ; Zhang Q; Lu J; Qian FF; Zhang LL; Hu F; Li CH; Cao SH; Li JW; Wang Y; Zhang XY; Xu MD; Han BH
    Acta Pharmacol Sin; 2022 Jan; 43(1):157-166. PubMed ID: 33758355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SOX9 promotes the invasion and migration of lung adenocarcinoma cells by activating the RAP1 signaling pathway.
    Yang JF; Liao Q; Lu CL
    BMC Pulm Med; 2023 Nov; 23(1):421. PubMed ID: 37919693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circ_001042 Inhibits TGF-
    Zhou L; Chen W; Yang H; Liu J; Meng H
    Evid Based Complement Alternat Med; 2022; 2022():7890490. PubMed ID: 35966723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Down-regulation of CLEC3B facilitates epithelial-mesenchymal transition, migration and invasion of lung adenocarcinoma cells.
    Lu X; Shen J; Huang S; Wang H; Liu D
    Tissue Cell; 2022 Jun; 76():101802. PubMed ID: 35500520
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Wu C; Dong B; Huang L; Liu Y; Ye G; Li S; Qi Y
    Front Oncol; 2021; 11():754290. PubMed ID: 34745988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-30a-5p Regulates Viability, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting ECT2.
    Chen S; Zhu X; Zheng J; Xu T; Xu Y; Chen F
    Comput Math Methods Med; 2021; 2021():6241469. PubMed ID: 34306175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plakophilin-2 Promotes Lung Adenocarcinoma Development via Enhancing Focal Adhesion and Epithelial-Mesenchymal Transition.
    Wu Y; Liu L; Shen X; Liu W; Ma R
    Cancer Manag Res; 2021; 13():559-570. PubMed ID: 33519235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long non-coding RNA SNHG17 promotes lung adenocarcinoma progression by targeting the microRNA-193a-5p/NETO2 axis.
    Zhang Z; Yan Y; Zhang B; Ma Y; Chen C; Wang C
    Oncol Lett; 2021 Dec; 22(6):818. PubMed ID: 34671432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness
    Guo H; Li T; Peng C; Mao Q; Shen B; Shi M; Lu H; Xiao T; Yang A; Liu Y
    Hum Exp Toxicol; 2022; 41():9603271221138971. PubMed ID: 36461613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.